While HPLC and mass spec make inroads into nontraditional markets, interest remains in molecular techniques that address the unique needs of clinicians and drug developers.
Immunoassay plates are utilized for a range of mainly ELISA-based applications, some of which are extremely sensitive and contain detection limits in the range of 10 fmol.
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes
Run a Search
We’ve updated our Privacy Policy to make it clearer how we use your personal data.
Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.